{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:03:28Z","timestamp":1787223808109,"version":"build-2736575974"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2139,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2230.2009.03650.x","type":"journal-article","created":{"date-parts":[[2009,10,23]],"date-time":"2009-10-23T14:36:22Z","timestamp":1256308582000},"page":"531-536","source":"Crossref","is-referenced-by-count":26,"title":["Inhibitory effects of antipsychotic and anxiolytic agents on stress-induced degranulation of mouse dermal mast cells"],"prefix":"10.1093","volume":"35","author":[{"given":"T.","family":"Shimoda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kawana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,10,23]]},"reference":[{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2003.10.041","article-title":"Critical role of mast cells in inflammatory disease and the effect of acute stress","volume":"146","author":"Theoharides","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1006\/brbi.1998.0541","article-title":"Acute immobilization stress triggers skin mast cell degranulation via corticotrophin releasing hormone, neurotensin, and substance P: a link to neurogenic skin disorders","volume":"13","author":"Singh","year":"1999","journal-title":"Brain Behav Immun"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1034\/j.1600-0625.2003.120106.x","article-title":"Corticotrophin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats","volume":"12","author":"Kaneko","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jdermsci.2005.12.004","article-title":"Role of substance P in stress-derived degranulation of dermal mast cell in mice","volume":"42","author":"Kawana","year":"2006","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.all.0000244793.03239.40","article-title":"Anxiety in allergy and atopic dermatitis","volume":"6","author":"Hashizume","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0002-9440(10)63877-1","article-title":"Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways","volume":"162","author":"Arck","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.182.4111.499","article-title":"Dopaminergic terminals in the rat cortex","volume":"182","author":"Thierry","year":"1973","journal-title":"Science"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1749-6632.1988.tb42102.x","article-title":"Stress and the mesocorticolimbic dopamine system","volume":"537","author":"Roth","year":"1988","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/S0022-3565(25)24006-X","article-title":"Differential receptor reserve for 5-HT1A receptor-mediated regulation of plasma neuroendocrine hormones","volume":"271","author":"Meller","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1254\/jjp.46.311","article-title":"Interaction of SM-3997 with serotonin receptor in rat brain","volume":"46","author":"Shimizu","year":"1988","journal-title":"Jpn J Pharmacol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000123454","article-title":"Organization of ovine cort icotrophin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study","volume":"36","author":"Swanson","year":"1983","journal-title":"Neuroendocrinology"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB12|cit12","first-page":"164","article-title":"Corticotrophin-releasing hormone in humans","volume":"13","author":"Orth","year":"1992","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1471-4892(01)00117-5","article-title":"Corticotrophin-releasing factor receptors 1 and 2 in anxiety and depression","volume":"2","author":"Reul","year":"2002","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S0022-3565(24)38220-5","article-title":"Receptor binding, behavioral and electrophysiological profiles of nonpeptide corticotrophin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001","volume":"289","author":"Okuyama","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1096\/fj.01-0254fje","article-title":"In situ expression of corticotrophin-releasing hormone (CRH) and proopiomelanocortin (POMC) genes in human skin","volume":"15","author":"Kono","year":"2001","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2005.10.002","article-title":"Neuroimmunoendocrine circuitry of the \ufffd\ufffd\ufffdbrain-skin connection\ufffd\ufffd\ufffd","volume":"27","author":"Paus","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tips.2004.09.007","article-title":"Mast cells as targets of corticotrophin-releasing factor and related peptides","volume":"25","author":"Theoharides","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"7665","DOI":"10.4049\/jimmunol.174.12.7665","article-title":"Human mast cells express corticotrophin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor","volume":"174","author":"Cao","year":"2005","journal-title":"J Immunol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1210\/endo.139.1.5660","article-title":"Corticotrophin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects","volume":"139","author":"Theoharides","year":"2006","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1073\/pnas.0602210103","article-title":"Corticotrophin-releasing hormone induces skin vascular permeability through a neurotensin-dependent process","volume":"16","author":"Donelan","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1096\/fj.04-2079rev","article-title":"The cutaneous serotoninergic\/melatoninergic system: securing a place under the sun","volume":"19","author":"Slominski","year":"2005","journal-title":"FASEB J"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF01966694","article-title":"Inhibition of histamine release and ionophore-induced calcium flux in rat mast cells by lidocaine and chlorpromazine","volume":"9","author":"Johnson","year":"1979","journal-title":"Agents Actions"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-4362.2001.01272.x","article-title":"Anxiety level and severity of skin condition predicts outcome of psychotherapy in atopic dermatitis patients","volume":"40","author":"Linnet","year":"2001","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/000155598442962","article-title":"Morphological assessment of the effects of cyclosporine A on mast cell-nerve relationship in atopic dermatitis","volume":"78","author":"Toyoda","year":"1998","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2230.2009.03650.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s004030050249","article-title":"Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis","volume":"289","author":"Chan","year":"1997","journal-title":"Arch Dermatol Res"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2230.2009.03650.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2230.2009.03650.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T22:14:45Z","timestamp":1739398485000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/35\/5\/531\/6622136"}},"subtitle":["The effects of antipsychotic and anxiolytic agents on mouse dermal mast cells"],"short-title":[],"issued":{"date-parts":[[2009,10,23]]},"references-count":25,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03650.x","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,23]]}}}